BMT CTN 1101 is a Phase III randomized controlled trial evaluating the comparative effectiveness of double unrelated umbilical cord blood ( dUCB ) versus HLA-haploidentical related donor bone marrow ( haplo-BM ) donor cell sources for blood or bone marrow transplantation ( BMT ) in patients with hematologic malignancies .